Saturday, October 31, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 31, 2026

Flag Ship Acquisition Q4 Earnings Call Highlights

View original at finance.yahoo.com
Flag Ship Acquisition Q4 Earnings Call Highlights Flag Ship Acquisition logo Key Points Forum Markets has moved from concept to execution in RWA tokenization with the February launch of Eurus Aero Token One and is building an asset origination pipeline via partnerships with Aero Engine Solutions, Karus, and Zippi to ta…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The company is focused on bringing real-world credit on chain, targeting verticals such as auto credit, residential lending, equipment finance, and commercial real estate

    60% confidence
  • The company's model does not require Ethereum price exposure or token price speculation, but instead relies on real assets generating real cash flows with tokenization as the scaling mechanism on top

    60% confidence
  • The company has eliminated direct ETH price exposure

    60% confidence
  • The approach combines immediate cash flow generation while building long-term scale

    60% confidence
  • The company now holds approximately $103 million in cash and has zero net debt

    60% confidence
  • Blockchain-based settlement could reduce friction created by fragmented, manual, and batch processes

    60% confidence
  • These markets remain largely untokenized and inaccessible

    60% confidence
  • Plans to deploy cash into asset purchases in the coming months

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com